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FEMALE AGGRESSION AGAINST MALES DOCUMENTED
E. Goulmy, A. van Leeuwen, B.A. Bradley, A. Munro, and J.J.
van Rood. Dept. of Immunohaematology, üniversity Hospital
Leiden, Holland.
The prognosis of bone marrow transplantation when determined
by GVH is less good, when the donor is a female and the reci-
pient a male.
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Question: Can anti H-Y immunity be detected in vitro ?
Änswer: Two out of 10 hyper-immunized women had lympholytic
effector cells directed against HLA-A2 positive males.
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One patient (Mrs. Reef) had formed antibodies which reacted in
a two colour fluorescence cytotoxicity test (TCF) with a
fraction of inononuclear cells (null or κ cells ?) of HLA-A2
positive male donors. Good correlation with CML results are
shown.
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H-2 PUBLIC SPECIFICITIES 28 AND 1; DO THEY OR DON'Τ ΤΗΕΥ ?
C. Neauport-Sautes, M. Joskowitz, and P. Demant.
Laboratory of Cellular Immunology, IRSC, Villejuif, France,
and Division of Genetics, The Netherlands Cancer Institute,
Amsterdam, Holland.
Antisera against the public specificities H-2.28 and H-2.1,
when tested by indirect precipitation or by antibody-induced
redistribution (capping) reveal in the product of the D region
of the H-2 complex a molecule (molecules) distinct from those
bearing the D region private specificity. This new molecule
has physio-chemical properties similar to those of the classi-
cal MHS antigens (H-2K, H-2D, HLA-A, HLA-B) and is controlled
by a separate locus, H-2L, in the D region. In all haplotypes
tested the H-2L locus seems to have one of the two types of
alleles, determining either the specificity H-2.28 or H-2.1.
In this respect the polymorphism of H-2L genes resembles that
of the 4a/4b antigens of HLA.
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*The mutual position of the H-2D and H-2L loci is not known.
H-2/HLA CROSS REACTION
Pavol Ivanyi. Central Laboratory of the Dutch Red Cross Blood-
transfusion Service, Amsterdam, Holland.
Previous experiments have shown that certain mouse alloimmune
anti-H-2 sera used in the microcytotoxicity assay with human
lymphocytes show a significant correlation with the presence
of certain HLA antigens, namely A2, A9, B7, B27. In recent
studies an anti-H-2D serum (BIO.Α donors, BIO.Α (4R) reci-
pient) showed a significant correlation with All and Aw31 HLA
antigens. Our Interpretation of these findings is that this
H-2 serum cross-react with HLA antigens previously not clas-
sified as belonging to one group of cross-reacting antigens
as defined by human alloimmune sera (ALLO-CREGs). We presume
that this mouse alloimmune H-2 serum detects some kind of
hitherto "hidden" relationships among HLA antigens (XENO-CREGs)
Alternatively, the H-2 serum might detect a distinct product
which occurs in linkage disequilibrium with the components of
the XENo-CREG.
